This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
All Eyes Set on June FOMC Meeting
by Zacks Equity Research
All Eyes Set on June FOMC Meeting.
Big Week With a Slew of Key Economic Data and Fed's FOMC
by Zacks Equity Research
U.S. stock futures are trading higher to start a crucial week for the global financial markets.
Strategic Buyouts Support UBS Group AG (UBS), High Costs Ail
by Zacks Equity Research
Various efficiency programs and strategic acquisitions support UBS Group AG's (UBS) financials. However, expectations of a decline in NII and rising costs are concerning.
UBS Gets Capital Regulatory Relief, Updates on Loss Guarantee
by Zacks Equity Research
UBS Group AG (UBS) gets an extended timeline of early 2026 to phase in the higher capital requirement rules owing to the Credit Suisse buyout. The Loss Protection Agreement is to be finalized by Jun 7.
UBS Group (UBS) Expects to Close Credit Suisse Deal By Jun 12
by Zacks Equity Research
UBS Group (UBS) expects to close Credit Suisse deal as early as Jun 12, 2023. Also, Credit Suisse shareholders will receive one UBS Group share for every 22.48 outstanding shares held.
UBS Group (UBS) to Keep 100 Credit Suisse IB Jobs in Asia
by Zacks Equity Research
UBS Group (UBD) plans to fortify its talent pool across Asia to better compete with its rival with a stronger presence by retaining more than 100 investment bankers of Credit Suisse post the merger.
UBS Group (UBS) to Shut TBA Trading in US Mortgage Unit
by Zacks Equity Research
UBS Group (UBS) plans to wind down to-be-announced ("TBA") trading in U.S. mortgage unit. This is in line with efforts to shift business strategy and concentrate on financing mortgage originators.
UBS' Buyout of Credit Suisse Gets EU Antitrust Approval
by Zacks Equity Research
UBS Group AG's (UBS) acquisition of Credit Suisse Group AG receives the European Commission's nod after the latter concluded that the deal would not raise competition concerns.
UBS (UBS) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
UBS (UBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bank of Montreal (BMO) Stock Down 4.6% as Q2 Earnings Fall Y/Y
by Zacks Equity Research
The acquisition of Bank of the West supports Bank of Montreal's (BMO) fiscal Q2 results as revenues increase. Yet, higher expenses and provisions act as headwinds.
UBS Group (UBS) Notes Likely Losses, Gains From Credit Suisse Deal
by Zacks Equity Research
Fair value adjustments of the combined group's financial assets and liabilities, litigation provisions, and other factors are expected to hit UBS Group (UBS) shareholders' equity by $28.3 billion.
Mitsubishi UFJ (MUFG) Earnings Decline Y/Y in Fiscal 2022
by Zacks Equity Research
An increase in expenses, credit costs and net trading loss affect Mitsubishi UFJ's (MUFG) earnings for fiscal 2022. Nonetheless, rising gross profits, NII, net fees and commissions are positives.
Itau Unibanco (ITUB) Q1 Earnings & Revenues Increase Y/Y
by Zacks Equity Research
Increased operating revenues and managerial financial margin are partially offset by escalating costs for Itau Unibanco (ITUB) in first-quarter 2023.
New Strong Sell Stocks for May 5th
by Zacks Equity Research
LPX, HHS and UBS have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2023.
HSBC Q1 Pre-Tax Earnings Improve as Revenues Rise, Costs Fall
by Zacks Equity Research
HSBC records a significant rise in revenues in the first quarter of 2023.
Zacks.com featured highlights Dutch Bros, UBS, CoStar, and Semtech
by Zacks Equity Research
Dutch Bros, UBS, CoStar, and Semtech have been highlighted in this Screen of The Week article.
Barclays (BCS) Gains as Q1 Earnings & Revenues Improve Y/Y
by Zacks Equity Research
Barclays (BCS) records a rise in revenues and expenses in the first quarter of 2023.
Discard These 4 Toxic Stocks to Safeguard Your Portfolio
by Lavina Shahu
The correct detection and removal of toxic stocks at the correct time are crucial to overall portfolio health. You should sell BROS, UBS, CSGP and SMTC.
UBS Q1 Earnings & Revenues Decline Y/Y, Expenses Escalate
by Zacks Equity Research
A rise in operating expenses and a fall in total revenues hinder UBS' Q1 earnings. Also, the Business divisions' performances are not impressive.
Big Tech Names Report: Global Week Ahead
by John Blank
The bulk of the S&P500 index components start to report Q1-23 earnings. The U.S. dollar could see if it has regained FX market appeal.
CPI Lands, U.S. Financials Report: Global Week Ahead
by John Blank
A balancing act -- between slowing global growth and sticky global price pressures -- sits at the top of the World Bank and IMF agendas.
Regional Banks vs. Tech: What Lies Ahead?
by Andrew Rocco
With tech stocks extended and regional banks breaking down, now may be an ideal time to be patient and "wait for your pitch". Andrew Rocco explains.
Company News for Apr 4, 2023
by Zacks Equity Research
Companies In The Are: TSLA, UBS, UNH, SAIC.
The Zacks Analyst Blog Highlights First Republic, Credit Suisse, UBS and Citigroup
by Zacks Equity Research
First Republic, Credit Suisse, UBS and Citigroup are included in this Analyst Blog.
Banking Turmoil: What's Happening This Time?
by Derek Lewis
Investors can't catch a break from banking headlines, with fears of contagion taking the majority of focus as of late. And just over the weekend, investors were met with another significant headline.